Pikralida is a biotechnology company that integrates research and development of innovative therapies (R&D) with Contract Research Organization (CRO) services.
As a clinical-stage company, we focus on both proprietary drug development and partnered pharmaceutical research, ensuring a diversified approach that drives innovation and commercial potential. Our mission is to build a high-value portfolio of projects, ultimately leading to future licensing or strategic partnerships for global market introduction.
Our flagship development program is centered around PKL-021 (marimastat), a subnanomolar matrix metalloprotease (MMP) inhibitor with broad therapeutic potential. We are advancing a pipeline of novel applications, with initial clinical-stage programs targeting:
🧠 Neuroprotection (stroke) – therapies designed to minimize long-term neurological damage and improve patient outcomes in ischemic stroke and brain injuries.
⚡ Snakebite envenoming – innovative pre-hospital treatment solutions, including an oral therapy designed to improve accessibility and survival rates in snakebite cases.
Beyond these priority projects, Pikralida maintains an expanding pipeline of preclinical and early-stage programs, exploring additional indications such as diabetic retinopathy and other high-impact therapeutic areas.
In addition to our own R&D pipeline, Pikralida operates as a specialized CRO, offering tailored research and development services to biotech and pharmaceutical companies. Our expertise spans across formulation development and pharmaceutical analysis
📍 Founded in Poland | 🌍 Global ambitions | 🔬 Hybrid business model | 📅 Clinical-stage company
🌐 www.pikralida.eu
Company Details
- Employees
- 18
- Founded
- -
- Address
- Bukowska, 70 / B424,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pikralida.eu
- HQ
- Poznań, wielkopolskie
Pikralida Questions
Pikralida's website is http://www.pikralida.eu
Pikralida's LinkedIn profile is https://pl.linkedin.com/company/pikralida
Pikralida has
18 employees.
View email and phone details for 18
employees at Pikralida.
Pikralida's industry is
Biotechnology Research
Pikralida's top competitors are
Explorna Therapeutics,
Ryvu Therapeutics,
Selvita,
Celon Pharma S.a.,
Molecure,
Jjp Biologics,
Ardigen,
Syvento Biotech,
Bioinmed,
Captor Therapeutics Sa.
Pikralida's categories are Biotechnology Research
Pikralida's founding year is 2019
